AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.32
-1.70 (-2.98%)
May 29, 2026, 12:42 PM EDT - Market open
AnaptysBio Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, AnaptysBio stock has a consensus rating of "Strong Buy" and an average price target of $84.45. The average 1-year stock price forecast is 52.66% higher than the current stock price, while the lowest is $66 (+19.31%) and the highest is $140 (+153.07%).
Price Target: $84.45 (+52.66%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 7 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 27, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $69 → $70 | Buy | Maintains | $69 → $70 | +26.54% | May 23, 2026 |
| UBS | UBS | Buy Maintains $60 → $76 | Buy | Maintains | $60 → $76 | +37.38% | May 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 | Buy | Maintains | $93 | +68.11% | May 13, 2026 |
| Barclays | Barclays | Buy Reiterates $63 → $75 | Buy | Reiterates | $63 → $75 | +35.57% | May 13, 2026 |
Financial Forecast
Revenue This Year
155.53M
from 234.60M
Decreased by -33.71%
Revenue Next Year
202.39M
from 155.53M
Increased by 30.13%
EPS This Year
-3.17
from -0.46
EPS Next Year
-2.81
from -3.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 200.7M | 236.7M | ||||||
| Avg | 155.5M | 202.4M | ||||||
| Low | 130.0M | 154.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -14.5% | 52.2% | ||||||
| Avg | -33.7% | 30.1% | ||||||
| Low | -44.6% | -0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 0.70 | 5.66 | ||||||
| Avg | -3.17 | -2.81 | ||||||
| Low | -6.39 | -8.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.